Skip to content

Comprehensive dynamic evaluation of physiological data and digital intervention for motion sickness

Comprehensive dynamic evaluation of physiological data and digital intervention for motion sickness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096337
Enrollment
Unknown
Registered
2025-01-22
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motion Sickness

Interventions

Motion sickness group (Part 2):(1) Mobile phone intervention test: Ride the test vehicle with the anti-corona system not turned on, and play games with the test mobile phone with the anti-corona funct
Control group (Part 2):(1) Mobile phone intervention test: Ride the test vehicle with the anti-corona system not turned on, and play games with the test mobile phone with the anti-corona function tur
Motion sickness group (Part 1):None
Motion sickness group (Pilot):None
Control group (Pilot):None

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Motion sickness group: (1)Age requirement: Adults between 18 and 65 years old, regardless of gender. (2)Have a clear history of motion sickness, experience motion sickness symptoms in at least the past one year, use standardized Motion Sickness susceptibility questionnaire -long(MSSQ-L), and score at a medium or above level. (3) Health status: overall good health, no serious chronic diseases; No known cardiovascular, respiratory, neurological, or psychiatric diseases, excluding health problems that might affect physiological markers or interfere with test results. (4)Physiological state: basic physiological indicators such as blood pressure, heart rate and body temperature are within the normal range. (5) Vision and hearing: normal vision or normal after correction (contact lenses can be worn); Hearing is normal. (6)Ability to participate in the test: able to understand and follow the test instructions, able to accurately report subjective feelings. (7)Willing and able to participate in the full trial process, including necessary follow-up. (8) Technical adaptability: familiar with basic smartphone operation (for mobile phone anti-corona application test). (9) Informed consent: Be willing to sign informed consent to understand the discomfort and risks that the test may bring. Control group (1)Age requirement: Adults between 18 and 65 years old, regardless of gender. (2) If there is no clear history of motion sickness, the simplified Chinese version of the Motion Sickness Susceptibility Questionnaire (such as Motion sickness susceptibility questionnaire-long, MSSQ-L) is used, and the scores are not susceptible or mildly susceptible. (3) Health status: overall good health, no serious chronic diseases; No known cardiovascular, respiratory, neurological, or psychiatric diseases, excluding health problems that might affect physiological markers or interfere with test results. (4) Physiological state: basic physiological indicators such as blood pressure, heart rate and body temperature are within the normal range. (5) Vision and hearing: normal vision or normal after correction (contact lenses can be worn); Hearing is normal. (6)Ability to participate in the test: able to understand and follow the test instructions, able to accurately report subjective feelings. (7)Willing and able to participate in the full trial process, including necessary follow-up. (8) Technical adaptability: familiar with basic smartphone operation (for mobile phone anti-corona application test). (9) Informed consent: Be willing to sign informed consent to understand the discomfort and risks that the test may bring.

Exclusion criteria

Exclusion criteria: (1)Have any chronic disease that may affect physiological indicators or interfere with test results, such as cardiovascular disease (e.g., hypertension, arrhythmia, coronary heart disease); Respiratory diseases (e.g. asthma, chronic obstructive pulmonary disease); Neurological disorders (e.g. epilepsy, multiple sclerosis); Mental illness (e.g., anxiety, depression); Diseases of the endocrine system (such as diabetes, thyroid dysfunction); A history of vestibular dysfunction or balance problems; A history of medical conditions that may affect CS sensitivity, such as migraine headaches. (2) Drugs are being used that may affect the results of the trial, such as: anti-CS drugs; Drugs that affect the central nervous system (e.g. sedatives, antidepressants); Drugs that affect the cardiovascular system (such as beta blockers); Drugs that affect vestibular function; A history of drug or alcohol dependence. (3) Special physiological status: pregnant or lactating women; Have undergone major surgery recently (within 3 months); She has a history of syncope. (4) Audiovisual function: severe uncorrected vision problems; Color blindness or color weakness (may affect response to visual stimuli); Severe hearing loss. (5)Test related: individuals who are unable to understand or follow the instructions of the test; Allergic to any equipment or materials used in the test; Claustrophobic (may not tolerate simulated environments). (6)Previous participation: Participated in other clinical trials that may have affected the results of this study within the past 1 month; Have participated in similar CS studies and may be too familiar with the trial procedure. (7) Occupation-related: professional drivers or people who often drive long distances (may have abnormal adaptability to CS); Professional athletes or balance training professionals (may have atypical vestibular function). (8)Age related: individuals under the age of 18 or over the age of 65. (9) Special cases: people with a history of severe CS (symptoms are so severe that they may not be able to complete the entire course of the test); Individuals who have extreme fear or anxiety responses to simulated exercise environments. (10) Device compatibility: Implanted medical devices (such as pacemakers) that may interfere with the test device. (11)Impediment to data collection: Abnormal skin condition that may interfere with the collection of physiological data (e.g. severe eczema or dermatitis); Individuals who are unable to remain seated for long periods of time or hold specific postures. (12)Legal relevance: individuals who are unable to provide valid informed consent; An individual under legal guardianship.

Design outcomes

Primary

MeasureTime frame
Physiological data set;

Secondary

MeasureTime frame
EMG, ECG;Simulator Sickness Questionnaire, SSQ;

Countries

China

Contacts

Public ContactWang Yue

Huashan Hospital, Fudan University

wang_yue_0_0@163.com+86 138 1703 9636

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026